Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Biomolecular Screening
|
January 9, 2004
Statistical and graphical methods for quality control determination of high-throughput screening data
Bert Gunter, Christine Brideau, Bill Pikounis, et al.
Journal of Biomolecular Screening
|
January 9, 2004
Improved statistical methods for hit selection in high-throughput screening
Christine Brideau, Bert Gunter, Bill Pikounis, et al.
Journal of Biomolecular Screening
|
August 17, 2005
An automated multistep high-throughput screening assay for the identification of lead inhibitors of the inducible enzyme mPGES-1
Frédéric Massé, Sébastien Guiral, Louis-Jacques Fortin, et al.
American Journal of Veterinary Research
|
April 14, 2004
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis
Margaret E McCann, Donald R Andersen, Donghui Zhang, et al.
Journal of Biomolecular Screening
|
August 9, 2011
Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods
Martine Hamel, Martin Henault, Huda Hyjazie, et al.
American Journal of Veterinary Research
|
August 23, 2005
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia
Margaret E McCann, Eric L Rickes, Donald F Hora, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2003
Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors
Bernard Côté, Richard Frenette, Sylvie Prescott, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2010
Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1
Tom Y H Wu, Hélène Juteau, Yves Ducharme, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2002
Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters
Richard Frenette, Marc Blouin, Christine Brideau, et al.
European Journal of Pharmacology
|
February 24, 2007
Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species
Steven E Rowland, Patsy Clark, Robert Gordon, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Biomolecular Screening
|
January 9, 2004
Statistical and graphical methods for quality control determination of high-throughput screening data
Bert Gunter, Christine Brideau, Bill Pikounis, et al.
Journal of Biomolecular Screening
|
January 9, 2004
Improved statistical methods for hit selection in high-throughput screening
Christine Brideau, Bert Gunter, Bill Pikounis, et al.
Journal of Biomolecular Screening
|
August 17, 2005
An automated multistep high-throughput screening assay for the identification of lead inhibitors of the inducible enzyme mPGES-1
Frédéric Massé, Sébastien Guiral, Louis-Jacques Fortin, et al.
American Journal of Veterinary Research
|
April 14, 2004
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis
Margaret E McCann, Donald R Andersen, Donghui Zhang, et al.
Journal of Biomolecular Screening
|
August 9, 2011
Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods
Martine Hamel, Martin Henault, Huda Hyjazie, et al.
American Journal of Veterinary Research
|
August 23, 2005
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia
Margaret E McCann, Eric L Rickes, Donald F Hora, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2003
Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors
Bernard Côté, Richard Frenette, Sylvie Prescott, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2010
Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1
Tom Y H Wu, Hélène Juteau, Yves Ducharme, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2002
Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters
Richard Frenette, Marc Blouin, Christine Brideau, et al.
European Journal of Pharmacology
|
February 24, 2007
Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species
Steven E Rowland, Patsy Clark, Robert Gordon, et al.
Page
of 3